[Seite 63↓]


1 Gaziano, J. M.: Global Burden of Cardiovascular Disease, in Braunwald, Eugene (Hrsg), Douglas P. Zipes, Peter, Libby: Heart disease: a textbook of cardiovascular medicine 6.Auflage, Philadelphia 2001, S.1-18

2 Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med 1997; 337: 32-41

3 Alvaez J, Murday A 1995 Mitral valve repair . Br.J Hosp Med 53: 221-225

4 Hufnagel CA, Harvey WP, Rabil P, McDermott TF (1952) Surgical correction of aortic insufficiency. Surgery 35: 673-683

5 Harken DE, Soroff HS, Taylor WJ, Lefemine AA, Gupta SK, Lunzer S. Partial and complete protheses in aortic insufficiency. J Thorac Cardiovasc Surg 1960; 40: 744

6 Starr A, Edward ML, McCord CW, Griswold HE. Aortic replacement: clinical experience with a semirigid ball-valve prothesis. Circulation 1963; 27: 779.

7 Korossis SA, Fisher J, Ingham E (2000) Cardiac valve replacement: a bioengineering approach. Biomed Mater Eng 10: 83-124

8 BraunwaldE. 1997, Valvular heart disease. In: Heart disaese 5th edition, Braunwald E ed. Philadelphia: Saunders Company

9 Cannegieter SC, Rosendaal FR, Briet E. 1994, Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation; 89: 635-641

10 Vonpatanasin W, Hillis D, Lange RA: Prosthetic heart valves. N Engl J Med 1996; 335: 407.

11 Miller DC. Predictors of outcome in patients with prosthetic valve endocarditis (PVE) and potential advantages of homograft aortic root replacement for prosthetic ascending aortic valve-graft infections. J Cardiac Surg 1990; 5: 53-62.

[Seite 64↓]

12 Butany J, Fayet C, Ahluwali MS, Blit P, Ahn C, Munroe Cusimano RJ, Leask RL (2003) Biological replacement heart valves: identification and evaluation. Cardiovasc Pathol 12: 119-139

13 Bloomfield P, Wheatley DJ,Prescott RJ, Miller HC. Twelve year comparison of Björk-Shiley mechanical valve with porcine bioprotheses. N Engl J Med 1991; 324: 573-9

14 Hammermeister KE, Sethi GK, Henderson WG et al. 1993, A comparison of outcomes in men 11 years after heart-valve replacement with mechanical valve or bioprosthesis. N Engl J Med; 328: 1289-1296

15 Mitchell RN, Jonas RA, Schoen FJ (1995) Structure function correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg : 60: 108-113

16 Angell WW, Oury JH, Lamberti JJ, Kozio lJ (1989) Durability of the viable aortic allograft. J Thorac Cardiovasc Surg 98: 48-55

17 Rajani B, Mee RB, Ratcliff NB. 1998, Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg; 115: 111-17

18 Yankah AV, Wottge HU. 1997, Allograft conduit wall calcification in a model of chronic arterial graft rejection. J Card Surg.Mar-Apr; 12(2): 86-92

19 Jamieson WR. 1993, Modern cardiac valve devices: bioprostheses and mechanical prostheses: state of the art. J Card Surg; 8: 89-98

20 Carabello BA, Crawford FA, Jr: Valvular Heart Disease. New Engl J Med 1997; 337: 32

21 Jamieson WR. 1993, Modern cardiac valve devices: bioprostheses and mechanical prostheses: state of the art. J Card Surg; 8: 89-98

22 Langer R, Vacanti JP. Tissue Engineering. Science. 1993 May 14; 260(5110): 920-6. Review

23 Fuchs JR, Nasserie BA, Vacanti JP Tissue Engineering: A 21 st century solution to surgical reconstruction. Ann Thorac Surg 2001, 72: 577-591

24 Wilson GJ, Courtman DW, Klement P, Lee MJ, Yeger H. 1995, Acellular matrix: a biomaterials approach for coronary artery and heart valve replacement. Ann Thorac Surg; 60: S353-S358

25 Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A: Tissue engineering of heart valves – human endothelial cell seeding of detergent acellularized porcine valves. Europ Journal of Cardiothoracic Surgery, 1998.

26 Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation. 2000 Nov 7; 102(19 Suppl 3): III50-5.

27 Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003 Jun; 23(6): 1002-6.

28 Ye Q, Zünd G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S, Hubbell JA, Turina M. 2000, Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg. May; 17(5): 587-91

29 Jockenhoevel S, Chalabi K, Sachweh J, Groesdonk HV, Demircan L, Messmer BJ (2001) Tissue engineering: complete autologous valve conduit- a new moulding technique. Thorac Cardithorac Surg 49: 287-290

30 Puelacher WC, Mooney D, Langer R, Upton J, Vacanti JP, Vacanti CA. Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes. Biomaterials. 1994 Aug; 15(10): 774-

31 Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science. 1999 Apr 16; 284(5413): 489-93

32 Choi RS, Vacanti JP. Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transplant Proc. 1997 Feb-Mar; 29(1-2): 848-51

33 Kaufmann PM, Sano K, Uyama S, Schloo B, Vacanti JP. Heterotopic hepatocyte transplantation using three-dimensional polymers: evaluation of the stimulatory effects by portacaval shunt or islet cell cotransplantation. Transplant Proc. 1994 Dec; 26(6): 3343-5.

34 Shinoka T, Ma PX, Shum-tim D., et a: Tissue engineering heart valves. Autologous valves leaflet replacement study in a lamb model. Circulation 94 ( Supp II): II164-II168, 1996

35 Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. 1995, Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. Dec; 60(6 Suppl): S513-6

36 Shinoka T, Mayer JE Jr: New frontiers in Tissue Engineering: Tissue Engineered heart valves. In: Synthetic biodegradable scaffold. Birkhaeuser Boston (1997)

37 Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, Stamp A, Taylor G, Moran AM, Landis W, Langer R, Vacanti JP, Mayer JE Jr. 1999, Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg. Dec; 68(6): 2298-304; discussion 2305

38 Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer Jr JE. Functional living trileaflet heart valves grown in vitro. Circulation 2000; 102(Suppl 3): III-44-III-49

39 Sodian R, Sperling JS, Martin DP, Egozy A, Stock U, Mayer JE Jr, Vacanti JP. 2000, Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng. Apr; 6(2): 183-8.

40 Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE: A new pulsative bioreactor for tissue engineering of heart valves. Tissue Eng. 2000; 6(1): 75–9.

41 Sodian R, Sperling JS, Martin DP, Stock U, Mayer Jr JE, Vacanti JP. Trileaflet heart valve scaffold for tissue engineering from a combined polymer. Tissue Eng 1999; 5(5).

42 Sodian R, Loebe M, Hein A, Martin DP, Hoerstrup SP, Potapov EV, Hausmann H, Lueth T, Hetzer R. 2002, Application of stereolithography for scaffold fabrication for tissue engineered heart valves. ASAIO J. Jan-Feb; 48(1): 12-6.

43 Fu P, Sodian R, Szymanski D, Hein A, Kraemer L, Hoerstrup SP, Lueth T, Hetzer R. Tissue Engineering of heart valves: scaffold fabrication using rapid prototyping technique. In review

44 Vacanti JP, Langer R. 1999, Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet. Jul; 354 Suppl 1: SI32-4.

45 Breuer CK, Shinoka T, Tanel RE, et al. 1996, Tissue engineering lamb heart valve leaflets. Biotechnol Bioeng; 35: 1961-65

46 Schnell AM, Hoerstrup SP, Zünd G, Kolb S, Sodian R, Visjäger JF, Grunenfelder J, Suter A, Turina M 2001, Optimal cell source for cardiovascular tissue engineering: venous vs. Aortic human myofibroblasts. Thorac Cardiov Surg; 49: 221-225.

47 Kadner A, Hoerstrup SP, Zund G, Eid K, Maurus C, Melnitchouk S, Grunenfelder J, Turina MI (2002) A new source for cadiovascular tissue engineering: human bone marrow stromal cells. Eur J Cardiothorac Surg 21: 1055-160

48 Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999, Multilineage potential of adult human mesenchymal stem cells. Science; 284: 143-147

49 Perry TE, Kaushal S, Sutherland FW, Guleserian KJ, Bischoff J, Sacks M, Mayer JE. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg. 2003 Mar; 75(3): 761-7; discussion 767.

50 Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kold SA, Grunenfelder J, Zund G,Turina M (2002) Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106 (suppl I): I-143-I150

51 Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of Human Endothelial Cells derived from Umbilical Veins. J.of Clinical Investigation Vol 52, 1973 2745-2756

52 Chih-Chang Chu. Biodegradable Poymeric Biomaterials: An Overview. In The biomedical engineering handbook, p 611-612J, D. Bronzino, CRC Press 1995

53 Kanda K, Matsuda T, Oka T: Mechanical stress induced cellular oriention and phenotypic modulation of 3-D cultured smooth muscle cells. ASAIO 39 (1993) M686-90

54 Hoerstrup SP, Sodian R. New Pulsatile Bioreactor for In Vitro Formation of Tissue Engineered Heart Valves. Tissue Engineering 2000; 6, 75-79

55 Madson DY et al. J Cancer Res Clin Oncol 101: 13-22, 1981

56 Cordell JL et al, J Histochem Cytochem 32: 219-229, 1984

57 Albelda, S.M. et al., J. Cell Bio., 114, 1059 (1991)

58 Cunningham, LW & Frederikson, D.W. (Eds) 1982, Structuure and contractile Proteins. Part A. Extracellular Matrix Methids in Enzymology 82, 1-558

59 Van der Rest, M, G.R., Collagen family of proteins. FASEJ., 1991. 5: 2814-23

60 Mayne R & Burgeson, R.E. (1987) Structure and Function of Collagen Types ; Academic Press, NY

61 Björn Reino Olsen. Matrix Molecules and their Ligands. Principles of Tissue Engineering. Second Ed. Lanza P. Langer R. Vacanti J., Academic Press, 2000 pp 63ff

62 Foo IT, Naylor IL, Timmons MJ, Trejdosiewicz LK. Intracellular actin as a marker for myofibroblasts in vitro. Lab Invest. 1992 Dec; 67(6): 727-33.

63 Bhattacharya S, Ying X, , Fu C, Patel R, Kuebler WM, Greenberg S, Bhattacharya J. 2000, α v ß 3 Integrin Induces Tyrosine Phosphorylation–Dependent Ca2+ Influx in Pulmonary Endothelial Cells. Circ Res; 86: 456-462.

64 Kirklin JK, Smith D, Novick W, et al. Long term function of cryopresered aortic homografts. J Thorac Cardiovasc Surg 1993; 106: 154-66

65 Jamieson WRE, TosadoJ, Munro AI, et al. Carpentier- Edwards standard porcine bioprothesis. Primary tissue failure (structural valve deteroration) by age groups. Ann Thorac Surg 1988; 46: 155-62

66 Vacanti CA, Vacanti JP the science of tissue engineering. Orthop Clin. North Am. 2000 Jul, 31 (3): 351-6.

67 Moony DJ, Vacanti JP. Tissue engineering using cells and synthetic polymers. Transplant Rev 1993, 7: 153-61

68 Shinoka T, Shum-D, MP PX, Tanel RE, Langer R, Vacanti JP, Mayer JE Jr (1997) Tissue-engineered heart valve leaflet: does cell origin affect outcome? Circulation 96(suppII): II-102-II-107.

69 Meryman HT. 1974, Freezing injury and its prevention in living cells. Ann Rev Biophys Bioeng; 3: 341-363

70 Locksley E McGann, Waterson ML. 1987, Cryoprotection by dimethyl sulfoxide and dimethyl sulfone. Cryobiology; 14: 451-465

71 Mironescu S. 1997, Hyperosmotic injury in mammalian cells. Survival of CHO cells in unprotected and DMSO- treated cultures. Cryobiology; 14: 451-465

72 Sodian R, Loebe M, Hein A, Martin DP, Hoerstrup SP, Potapo EV, Hausmann H, Lueth T, Hetzer R. 2002, Application of stereolithigraphy for scaffold fabrication for tissue engineering heart valves. ASAIO J. Jan-Feb; 48(1): 6-12

73 Sodian R, Sperling JS, Martin DP, Stock U, Mayer Jr JE, Vacanti JP. Trileaflet heart valve scaffold for tissue engineering from a combined polymer. Tissue Engineering 1999; 5(5)

74 Stock UA, Nagashima M, Khalil PN, Nollert GD, Herden T, Sperling JS, Moran A, Lien J, Martin DP, Schoen FJ, Vacanti JP, Mayer JE Jr. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg. 2000 Apr; 119(4 Pt 1): 732-40.

75 Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science. 1999 Apr 16; 284(5413): 489-93.

76 Kuebler WM, Ying X, Bhattacharya J. 2002, Pressure-induced endothelial Ca(2+) oscillations in lung capillaries. Am J Physiol Lung Cell Mol Physiol. May; 282(5): L917-23.

77 Ziegler T, Nerem RM., Tissue engineering a blood vessel: regulation of vascular biology by mechanical stresses. J Cell Biochem 1995; 56: 204-9

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: